We have recently demonstrated that laser ablation of a single epithelial cell reproducibly induces rapid and global airway constriction (1) . The dynamics of the response suggested that local epithelial injury released a soluble mediator(s) that was transported to underlying smooth muscle cells by diffusion. The soluble mediator(s) evoked multiple Ca 21 oscillations in smooth muscle cells by stimulating L-type voltage-dependent Ca 21 channels (VGCCs), thus increasing intracellular Ca 21 levels via the calcium-induced calcium release (CICR) mechanism. In this study, we investigated the specific nature of the soluble mediator (s) and signaling pathway(s) underlying the VGCC-mediated Ca 21 influx. In response to mechanical stimulation, ATP is released from airway epithelial cells and stimulates Ca 21 waves in the epithelium (2-4); however, the effects of local epithelial injury-induced ATP on airway caliber have not been studied. The level of intracellular ATP is high (millimolar range) for metabolism, but is extremely low in the extracellular space, where it can function as a signaling molecule (5) . Extracellular ATP activates two subtypes of purinergic receptors, P2X and P2Y, and both of them are expressed on airway epithelial and smooth muscle cells (6) . The P2X receptors are ligand-gated ion channels that mediate Ca 21 and Na 1 influx, and P2Y receptors are G protein-coupled receptors that regulate phospholipase C pathway, leading to inositol trisphosphate (IP 3 ) production and intracellular Ca 21 release (6). Because ATP has been shown to stimulate small airway contraction in mouse lung tissue slices by activating P2Y receptors (7) , it was a likely candidate to be the soluble mediator(s) involved in local epithelial injury-induced smooth muscle contraction. However, in our previous studies, we found that inhibition of P2 purinoceptor receptors did not block Ca 21 signaling in smooth muscle cells and airway contraction induced by local epithelial injury. Furthermore, inhibition of P2 purinoceptor receptors or neutralizing ATP with apyrase did not block extracellular ATP-induced airway contraction. Thus, we previously ruled out the involvement of P2 purinoceptor receptors on smooth muscle cells in local epithelial injury-induced airway contraction, but we could not completely rule out ATP as a soluble mediator (1) .
Exogenous ATP is rapidly converted to its metabolic products, such as adenosine monophosphate (AMP), ADP, and adenosine by ecto-apyrase enzymes expressed on the cell surface (8) . Thus, ATP released from wounded single epithelial cells could potentially stimulate adenosine receptors after degradation to AMP (9) or adenosine (6, 10) . Adenosine receptors are G protein-coupled receptors and have four subtypes: A 1 , A 2A , A 2B , and A 3 receptors. Although the four adenosine receptors are all expressed on airway smooth muscle cells (6) , adenosine is traditionally considered to indirectly induce bronchoconstriction either through activating A 2B or A 3 receptors on mast cells or through neural nerves via A 1 receptors (11) (12) (13) (14) . However, recent studies demonstrated that adenosine could directly activate A 1 and A 2B receptors to regulate adenylyl cyclase on human tracheal smooth muscle cells (15) , and stimulate A 1 receptors on human bronchial smooth muscle cells to increase Ca 21 signaling (16) . Furthermore, adenosine A 1 receptors are colocalized with epidermal growth factor receptors (EGFRs) and induce the transactivation of EGFR and their downstream pathways, such as phosphoinositide 3-kinase and Src kinase in neural cells (17) .
Prostanoids, which are derived from arachidonic acid, include prostaglandins (PGE 2 , PGD 2 , and PGF 2 ), prostacyclins (PGI 2 ), and thromboxane (18) . Cyclooxygenase (COX-1 and COX-2) is an enzyme that converts arachidonic acid into the prostanoids. High levels of prostanoids in bronchoalveolar lavage fluid and the increased expression of COX-2 in lung tissue have been detected in subjects with asthma (18) . PGE 2 is produced by airway epithelial cells (19) (20) (21) and by smooth muscle cells (22) (23) (24) (25) , and has been demonstrated to regulate airway caliber (26) (27) (28) . There are four subtypes of PGE 2 receptors: EP [1] [2] [3] [4] . Activation of EP 2 or EP 4 receptors increases intracellular cyclic AMP level and causes relaxation of smooth muscles (29, 30) , whereas activation of EP 1 receptors increases intracellular Ca 21 and thus causes smooth muscle contraction (23, 31, 32) . EP 3 has multiple isoforms, and its activation can stimulate smooth muscle contraction through either decreasing cyclic AMP levels or increasing intracellular Ca 21 (30, 33) . The goal of this study was to identify the soluble mediator(s) and signaling pathway(s) mediating the local epithelial injuryinduced smooth muscle contraction in rat lung tissue slices. We hypothesized that adenosine and PGE 2 were both involved in the underlying mechanisms of local epithelial injury-induced airway contraction. Our results show that ATP is released from wounded single epithelial cells, and activates the following sequence of events: A 1 R→EGFR/PDGFR→COX-2→EP 3 →VGCCs→CICR, leading to the Ca 21 oscillations in smooth muscle cells and airway contraction.
MATERIALS AND METHODS

Materials
Fluo-4/AM, Pluronic F-127, Hanks' balanced salt solution (HBSS), Dulbecco's modified Eagle medium, and Antibiotic-Antimycotic were purchased from Invitrogen (Carlsbad, CA). AH6809, AG18, AG1478, AG1296, and 11-deoxy-16,16-dimethyl PGE 2 (11-PGE 2 ) were purchased from Cayman Chemical (Ann Arbor, MI). Sulfobromophthalein, ATP, adenosine 59-[g-thio]triphosphate tetralithium salt (ATP-g-S), indomethacin, L-798106, and N6-cyclopentyladenosine (CPA) were purchased from Sigma-Aldrich (St. Louis, MO). Adenosine, 9-chloro-2-(2-furanyl)- [1, 2, 4] triazolo [1,5- (34) .
Because the selectivity of an inhibitor is dependent on species (e.g., human versus rat) and cell type, for each chemical compound that we used in this study, we have provided detailed information for the concentration used based on the previous studies in rat (see Table E1 in the online supplement). Because molecular methods, such as small interfering RNA or lentivirus-based short hairpin RNA, to confirm the molecular mechanism in our current studies, introduce significant technical challenges in the lung tissue slice model, we applied multiple selective inhibitors to confirm our results.
Preparation of Lung Tissue Slices
All procedures involving animals were approved by the Institutional Animal Care and Use Committee of the University of California, Irvine, and were consistent with guidelines published by the National Institutes of Health. The preparation of rat lung tissue slices has been previously described in detail (1) , and the procedure is also available in the MATERIALS AND METHODS section of the online supplement.
Measurement of Intracellular Ca 21 Signaling
To monitor free intracellular Ca 21 in both epithelial and smooth muscle cells, lung tissue slices were incubated in sHBSS with 20 mM Fluo-4/AM, 100 mM sulfobromophthalein, and 0.2% Pluronic F-127 for 1 hour at room temperature (35) . Subsequently, the slices were kept in sHBSS with 100 mM sulfobromophthalein for another hour at room temperature. The slices were then transferred to a glass-bottom dish (MatTek, Ashland, MA) and held in place with a slice anchor (Warner Instruments, Hamden, CT). Confocal imaging was performed on a Zeiss 510 Meta multiphoton laser scanning microscope (LSM 510; Zeiss, Jena, Germany). Fluo-4 was excited with a 488-nm laser, and the fluorescence images (512 3 512 pixels) were collected.
Laser Ablation
The procedure for femtosecond (fs) laser ablation has been previously described in detail (1) . Briefly, the laser ablation was performed on the LSM 510 with an Achroplan 403/0.8 NA water-immersion objective. A single epithelial cell was ruptured by focusing the Mode-locked Ti: Sapphire femtosecond laser beam over a triangular region of interest (z6 mm 2 ) that included the apical membrane of the epithelial cell. The region of interest was scanned horizontally by the femtosecond laser at 100 ms/mm. By using the "bleach control" program in the LSM 510, we were able to immediately (less than 1 second) switch between the imaging mode and the ablation mode. The femtosecond laser beam was produced from a Coherent Chameleon system (Coherent, Santa Clara, CA) with 800-nm wavelength, 140-fs pulse duration, and 80-MHz repetition rate. The average power at the sample plane was z600 mW, the pulse energy was z7.5 nJ per pulse, and the peak power was z37.5 kW.
Statistical Analysis
The ratio of lumen area was defined as the minimum cross-sectional area of airways after treatment divided by initial cross-sectional area. Statistical tests of significance of the ratio of lumen area were performed with one-way ANOVA using commercial software (SPSS v. 16; SPSS, Chicago, IL), and a P value less than 0.05 was considered statistically significant.
RESULTS
Adenosine and A 1 Receptor Mediate the Local Epithelial Injury-Induced Airway Contraction
In our previous studies, we ruled out the involvement of P2 purinoceptor receptors on smooth muscle cells in local epithelial injury-induced airway contraction; however, we did not completely rule out ATP as a soluble mediator, because inhibition of P2 purinoceptor receptors did not block the ATP-induced airway contraction (1). One explanation for these results would be activation of adenosine receptors to stimulate airway contraction from ATP metabolites, such as AMP and adenosine. To test this possibility, we inhibited the adenosine receptors with 2 mM CGS15943, a nonselective adenosine receptor antagonist (36, 37) . Laser ablation of single epithelial cells induced an increase in Ca 21 oscillations (see Figure E1A in the online supplement), and airway contraction to 70% of the original cross-sectional area ( Figures 1A and 1C and Movie E1). However, inhibition of adenosine receptors with CGS15943 completely blocked Ca 21 oscillations in smooth muscle cells and airway contraction induced by local epithelial injury, but did not block the Ca 21 wave in epithelial cells ( Figure 1C , Figure  E1B , and Movie E2). To confirm that adenosine is the soluble mediator, we incubated lung tissue slices with 5 units/ml adenosine deaminase (ADA), an enzyme that catalyzes the deamination of adenosine (38) , and found that ADA significantly blocked the local epithelial injury-induced airway contraction ( Figure 1C) .
Because all the four subtypes of the adenosine receptors (A 1 , A 2A , A 2B , and A 3 ) have been demonstrated to mediate smooth muscle contraction (5, (11) (12) (13) (14) (15) (16) (39) (40) (41) , we next investigated the roles of these four adenosine receptors. We found that selective inhibition of the A 1 receptor with 5-50 mM PSB36 (42, 43) To test the role of adenosine receptors in mediating ATP-induced airway contraction, we investigated the effects of ATP, its nonhydrolyzable analog, ATP-g-S, and adenosine on airway caliber in the presence and absence of adenosine receptor antagonist CGS15943. We found that 10 mM adenosine, ATP, or ATP-g-S induced airway contraction ( Figure 1D ). Inhibition of adenosine receptors with CGS15943 significantly blocked airway contraction induced by adenosine and ATP, but not by ATP-g-S ( Figure 1D ).
EP 3 Receptors Participate in the Local Epithelial Injury-Induced Airway Constriction PGE 2 has been shown to be released by mechanical scratch of the guinea pig tracheal mucosa (19) , indicating that epithelial cell damage could possibly increase PGE 2 levels in lung tissue. Thus, we investigated the role of PGE 2 in local epithelial injuryinduced airway contraction by inhibiting COX-2, an enzyme that mediates PGE 2 production. We found that inhibition of COX-2 with 20 mM indomethacin, a nonselective COX inhibitor (50) (51) (52) Figure E1D , and Movie E4).
Because there are four EP receptors presented on airway smooth muscle cells (55), we next attempted to determine whether a selective EP receptor(s) mediates the local epithelial injury-induced airway contraction. We found that 10-25 mM L-798106, a selective EP 3 antagonist (56-59), and 100 mM AH6809, a nonselective rat EP 1 , EP 2 , and EP 3 receptor inhibitor (59-61), completely blocked Ca 21 oscillations in smooth muscle cells and airway contraction induced by local epithelial injury, but did not block the Ca 21 wave in epithelial cells ( Figure 2B , Figure E1E , and Movie E5).
To investigate the order in which A 1 and EP 3 receptors were activated, we assessed the effects of CPA, a selective A 1 R agonist (45, 62) , and 11-PGE 2 , a stable synthetic analog of PGE 2 that selectively activates EP 3 receptor (61, 63), on airway caliber in the presence and absence of EP 3 receptor antagonist L-798106. We found that both 10 mM CPA and 11-PGE2 induced airway contraction ( Figure 2C ). Inhibition of EP 3 receptors with L-798106 significantly blocked airway contraction induced by CPA or 11-PGE 2 , but not by 25 mM KCl, a VGCC agonist ( Figure 2C ). However, inhibition of A 1 R with 50 mM PSB36 did not block airway contraction with 11-PGE 2 ( Figure 2C) . Thus, the role of A 1 R is upstream of EP 3 and VGCC in the activation of smooth muscle contraction after airway epithelial injury.
Adenosine A 1 R Activates EP 3 
Receptors via EGFR/PDGFR Pathway
It has been demonstrated that adenosine A 1 receptor mediates the transactivation of the EGFR in rat cortical neurons (17) , whereas activation of receptor tyrosine kinases, such as EGFR and PDGFR, could increase the production of PGE 2 in human or guinea pig tracheal smooth muscle cells (23, 24) . Thus, we hypothesized that receptor tyrosine kinases are necessary for adenosine A 1 R-mediated EP 3 receptor activation. To assess the role of receptor tyrosine kinases in local epithelial injury-induced airway contraction, we blocked receptor tyrosine kinases with 100 mM AG18, an inhibitor of EGFR and PDGFR (64) (65) (66) , and 10 mM AG1478 (24, 67, 68) or 10 mM AG1296 (68-70), which are selective inhibitors of EGFR and PDGFR, respectively. We observed that inhibition of EGFR or PDGFR significantly blocked Ca 21 oscillations in smooth muscle cells and airway contraction induced by local epithelial injury, but did not block the Ca 21 wave in epithelial cells ( Figure 3A , Figure E1F , and Movie E6). -c]quinazolin-5-amine (CGS15943) (CGS, a nonselective adenosine receptor antagonist; n ¼ 7 airways from 5 rats), inhibition of adenosine A 1 receptors with 5-50 mM PSB36 (50 mM for 15 min incubation time, or 5 mM for 60 min; n ¼ 5 airways from 3 rats for 50 mM PSB36 treatment) or 4 mM SLV320 (n ¼ 9 airways from 4 rats), or deletion of adenosine with 5 units/ml adenosine deaminase (ADA; n ¼ 4 airways from 3 rats) significantly blocked the airway contraction induced by local epithelial injury, whereas inhibition of adenosine A 2A receptors with 5 mM ZM241385 (n ¼ 4 airways from 2 rats), A 2B receptors with 10 mM PSB603 (n ¼ 6 airways from 5 rats), or A 3 receptors with 5 mM MRS1334 (n ¼ 8 airways from 6 rats) did not. (D) Statistical tests demonstrate that CGS15943 significantly blocked airway contraction induced by 10 mM adenosine (ADO, a nonselective adenosine receptor agonist; n ¼ 4 airways from 4 rats for N6-cyclopentyladenosine [CPA] and n ¼ 4 airways from 4 rats for CPA 1 CGS treatment) or 10 mM ATP (n ¼ 5 airways from 5 rats for ATP and n ¼ 4 airways from 4 rats for ATP 1 CGS), but not 10 mM ATP-g-S (n ¼ 6 airways from 4 rats for ATP-g-S and n ¼ 5 airways from 4 rats for ATP-g-S 1 CGS). As a positive control, 25 mM KCl or 1 mM acetylcholine was used to verify the viability and contractility of airway smooth muscle cells after laser ablation experiments for each treatment. The ratio of lumen area was defined as the minimum crosssectional area of airways after treatment divided by initial crosssectional area. Statistical tests of significance of the ratio of lumen area between control airways and each treatment condition were performed with one-way ANOVA, and there are similar numbers of control airways for each treatment condition. *P , 0.05 was considered statistically significant.
To demonstrate whether the receptor tyrosine kinase pathway is involved in adenosine A 1 R-mediated activation of EP 3 receptors, we stimulated A 1 and EP 3 receptors with CPA and 11-PGE2, respectively, in the presence and absence of EGFR inhibitor, AG1478. We found that inhibition of EGFR with 10 mM AG1478 significantly blocked airway contraction induced by 10 mM CPA, but not by 10 mM 11-PGE2 or 25 mM KCl ( Figure 3C) . Thus, the role of EP 3 and VGCC in the activation of smooth muscle contraction is downstream of EGFR.
DISCUSSION
Local epithelial injury induces airway hyperresponsiveness (1); however, the underlying mechanism has not been identified. In this study, we investigated the underlying mechanisms of the rapid (,10 s) communication between local epithelial injury and airway constriction by combining a lung tissue slice model with a femtosecond laser ablation technique. We first identified adenosine as the soluble mediator initiating local epithelial injury-induced airway contraction via A 1 R activation. We then revealed a novel signaling pathway that includes the sequence A 1 R→EGFR/PDGFR→COX-2→EP 3 →VGCCs→CICR, leading to increase in Ca 21 oscillations in airway smooth muscle cells and initiation of airway constriction. For the first time, we show a sequential link between adenosine A 1 R, receptor tyrosine kinases, including EGFR and PDGFR, and prostaglandin receptor EP 3 in airway smooth muscle cells.
ATP regulates multiple biological responses, such as airway hyperresponsiveness in the lungs (6) . As an energy source, ATP is maintained at a very high level in the cytoplasm of airway epithelial cells. Upon epithelial injury, the local concentration of ATP can rapidly increase to 125 mM (38) and initiate a Ca 21 wave in airway epithelium by activating P2Y receptors on epithelial cells (4) . However, the effects of local epithelial injuryinduced ATP release on airway caliber have not been studied. In this study, we found that local epithelial injury-induced ATP activated both airway epithelial and smooth muscle cells. Locally, ATP activates P2 purinergic receptors on neighboring epithelial cells; however, over the time (z5-10 s [1] ) it takes to diffuse to the underlying smooth muscle, ATP is rapidly (,1 s [71] ) degraded to adenosine, leading to the stimulation of adenosine A 1 receptors on smooth muscle cells (Figure 4) . The hypothesis that ATP is rapidly degraded into adenosine is supported by the results that ATP-induced airway contraction is blocked by inhibition of adenosine receptors ( Figure 1D ), but not by inhibition of P2 purinergic receptors (1) . In the present study, we confirmed the role of adenosine in the local epithelial injury-induced airway contraction by both inhibiting A 1 receptors and neutralization of adenosine with ADA; however, we cannot rule out the involvement of AMP, because AMP, which has been shown to activate A 1 receptors (9), might also be decreased by ADA.
ATP has been demonstrated to induce airway smooth muscle contraction through either directly activating P2X or P2Y on mouse airway smooth musle cells (7) or indirectly stimulating P2Y receptors on epithelial cells, which release prostaglandins in guinea pig trachea (20) . We can eliminate the direct effect of ATP on airway smooth muscle cells, because inhibition of P2X or P2Y on smooth muscle cells did not block the local epithelial injury-induced smooth muscle contraction (1). Furthermore, we can rule out the indirect effect of ATP on airway epithelial cells, because inhibition of P2 purinergic receptors on epithelial cells significantly decreased the Ca 21 wave in the epithelium, but did not block the local epithelial injury-induced airway contraction (1). Thus, we have identified a novel pathway in which adenosine derived from local epithelial injury-released ATP stimulates A 1 receptors on smooth muscle cells to initiate airway contraction in rat lung tissue slices.
The levels of adenosine in bronchoalveolar lavage fluid are increased in asthma, and hyperresponsiveness to adenosine is a hallmark of asthma (72) . Adenosine is traditionally thought to induce airway contraction indirectly by activation of adenosine receptors, Figure 2 . Prostaglandin E receptor 3 (EP 3 ) receptors mediate adenosine-induced airway contraction. (A) Statistical tests demonstrate that inhibition of cyclooxygenase (COX)-2 with 20 mM indomethacin (n ¼ 5 airways from 5 rats) or 10 mM NS-398 (n ¼ 4 airways from 2 rats) completely blocked local epithelial injury-induced airway contraction (n ¼ 10 control airways from nine rats). (B) Statistical tests demonstrate that inhibition of EP 3 receptor with 100 mM AH6809 (n ¼ 8 airways from 8 rats) or 10-25 mM L-798106 (25 mM for 20 min incubation time or 10 mM for 45 min; n ¼ 5 airways from 2 rats for 25 mM L-798106 treatment) completely blocked local epithelial injury-induced airway contraction (n ¼ 14 control airways from 10 rats). (C) Statistical tests demonstrate that L-798106 significantly blocked airway contraction induced by 10 mM CPA, an adenosine A 1 receptor agonist (n ¼ 5 airways from 3 rats for CPA and n ¼ 5 airways from 4 rats for CPA 1 L-798106), or 10 mM 11-prostaglandins E 2 (PGE 2 ), an EP 3 receptor agonist (n ¼ 9 airways from 5 rats for 11-PGE 2 and n ¼ 5 airways from 4 rats for 11-PGE 2 1 L-798106), but not 25 mM KCl, a L-type voltage-dependent Ca 21 channel (VGCC) agonist (n ¼ 6 airways from 4 rats for KCl and n ¼ 5 airways from 4 rats for KCl 1 L-798106). Inhibition of A 1 R with 50 mM PSB36 did not block airway contraction with 10 mM 11-PGE2 (n ¼ 4 airways from 2 rats). *P , 0.05 was considered statistically significant. Statistical tests demonstrate that inhibition of EGFR and PDGFR with 100 mM AG18 (n ¼ 4 airways from 3 rats), or inhibition of EGFR or PDGFR with 10 mM AG1478 (n ¼ 5 airways from 3 rats) and 10 mM AG1296 (n ¼ 4 airways from 2 rats), respectively, significantly blocked local epithelial injury-induced airway contraction (n ¼ 9 control airways from 5 rats). (B) AG1478 significantly blocked airway contraction induced by 10 mM CPA (n ¼ 5 airways from 2 rats for CPA and n ¼ 6 airways from 3 rats for CPA 1 AG1478), but not 10 mM 11-PGE 2 (n ¼ 6 airways from 4 rats for 11-PGE 2 and n ¼ 6 airways from 4 rats for 11-PGE 2 1 AG1478) or 25 mM KCl (n ¼ 6 airways from 5 rats for KCl and n ¼ 6 airways from 3 rats for KCl 1 AG1478). *P , 0.05 was considered statistically significant. either on neural nerves or on mast cells, which release acetylcholine and prostaglandins, respectively, to induce smooth muscle cell contraction (11) . However, we ruled out the involvement of sensory nerves in adenosine-induced airway contraction (11) (12) (13) (14) , because inhibition of acetylcholine M2 receptors with atropine did not block the local epithelial injury-induced airway contraction (1). We also ruled out the involvement of mast cell degranulation via A 2B receptor, because neither inhibition of A 2B receptor ( Figure 1C ) nor inhibition of mast cell degranulation with 300 mM cromolyn sodium (data not shown) blocked the local epithelial injury-induced airway contraction. Thus, we conclude that adenosine directly induces airway smooth muscle contraction by activation of A 1 receptors on the airway smooth muscle cells. Although adenosine has been shown to activate A 1 and A 2B receptors on human airway smooth muscle cells and regulate adenylyl cyclase and Ca 21 signaling (15, 16) , the underlying mechanism leading to mobilization of Ca 21 is not clear. In this study, we show that inhibition of EGFR/PDGFR completely blocks the local epithelial injury-induced airway contraction. We further demonstrate that inhibition of EGFR significantly blocks the A 1 R agonist-induced airway contraction, but not EP 3 agonist-induced contraction ( Figure 3C ). The results indicate that receptor tyrosine kinases, including EGFR and PDGFR, are necessary for A 1 R-mediated EP 3 activation. Our results are consistent with those of previous studies in which adenosine A 1 receptors mediated the transactivation of EGFRs in neural cells (17) . Because receptor tyrosine kinases regulate many cellular functions, such as cell migration, differentiation, proliferation, apoptosis, and inflammation (73, 74) , it is possible that local epithelial injury-induced receptor tyrosine kinase activation may have an even broader impact on pulmonary pathology. Multiple signaling pathways could be involved in EGFR/PDGFR-induced COX-2 production, such as phosphoinositide 3-kinase/Akt/NF-kB (24), mitogen-activated protein kinase kinase/mitogen-activated protein kinase (23, 75) , or c-Src (76) , and further study is needed to reveal the downstream signaling pathways.
Inhibition of COX-2 with indomethacin and NS-398 completely blocked the local epithelial injury-induced airway contraction, demonstrating the involvement of prostanoids in this process. To confirm this, we found that inhibition of EP 3 receptors also blocked the airway contraction induced by local epithelial injury. Although PGE 2 is traditionally considered an agonist of EP 3 receptors, PGI 2 has recently been shown to activate EP 3 receptors (59), indicating that either PGE 2 or PGI 2 could be released upon local epithelial injury. Our results are consistent with the studies in which activation of receptor tyrosine kinases leads to COX-2 expression (75-77) and PGE 2 generation (24) . Our results are also consistent with the studies showing that smooth muscle cell contraction can be stimulated by self-generated prostanoids (23) .
VGCC-mediated Ca 21 influx induces a large amount of intracellular Ca 21 release, which regulates numerous cellular functions, including smooth muscle contraction. In our previous study, we demonstrated that inhibition of VGCCs with nifedipine completely blocked local epithelial injury-induced airway contraction. We further showed that inhibition of A 1 and EP 3 receptors did not block KCl-induced airway contraction ( Figures 2C  and 3C ), whereas inhibition of VGCCs blocked A 1 and EP 3 receptor agonist-induced airway contraction (data not shown). These results suggest that A 1 R-, EGFR-, and EP 3 receptormediated pathways are upstream and dependent on VGCCs.
We acknowledge the use of relatively high concentrations of some chemical inhibitors in comparison to reported negative log dissociation constants or half maximal inhibitory concentration (IC 50 ) (Table E1) , and thus off-target effects for one or more of the compounds are possible. However, in our present study, we report a series of compelling observations (multiple agonists and antagonists for each receptor) that are all consistent with the revealed molecular pathway underlying local epithelial injury-induced airway contraction. Thus, it is essentially impossible that all potential offtarget effects would lead to the same set of conclusions.
In conclusion, we have identified a novel sequence of events that provides the underlying mechanism by which local airway epithelial injury can induce global airway smooth muscle contraction. Airway epithelial cell injury releases ATP, which is rapidly degraded to adenosine. Adenosine can diffuse to the underlying smooth muscle and initiates the activation of A 1 R, EGFR and PDGFR, COX-2, EP 3 , and VGCCs. Our studies provide direct evidence that local epithelial injury could contribute to airway hyperresponsiveness in subjects with asthma, and provides potentially new pharmacological targets for asthma treatment. 
